230 related articles for article (PubMed ID: 31049569)
1. Autophagy mediates 2-methoxyestradiol-inhibited scleroderma collagen synthesis and endothelial-to-mesenchymal transition induced by hypoxia.
Liu C; Zhou X; Lu J; Zhu L; Li M
Rheumatology (Oxford); 2019 Nov; 58(11):1966-1975. PubMed ID: 31049569
[TBL] [Abstract][Full Text] [Related]
2. 2-Methoxyestradiol inhibits hypoxia-induced scleroderma fibroblast collagen synthesis by phosphatidylinositol 3-kinase/Akt/mTOR signalling.
Zhou X; Liu C; Lu J; Zhu L; Li M
Rheumatology (Oxford); 2018 Sep; 57(9):1675-1684. PubMed ID: 29905853
[TBL] [Abstract][Full Text] [Related]
3. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models.
Li R; Yin H; Wang J; He D; Yan Q; Lu L
Clin Rheumatol; 2021 Oct; 40(10):4269-4277. PubMed ID: 34013490
[TBL] [Abstract][Full Text] [Related]
7. Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial-Mesenchymal Transition.
Cai J; Chen X; Chen X; Chen L; Zheng G; Zhou H; Zhou X
Cell Physiol Biochem; 2017; 41(3):1167-1178. PubMed ID: 28245473
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
Zhu L; Song Y; Li M
J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
[TBL] [Abstract][Full Text] [Related]
9. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
[TBL] [Abstract][Full Text] [Related]
10. [Knockdown of RUNX3 inhibits hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells].
Liu Y; Li B; Wang Y; Wang D; Zou J; Ke X; Hao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1627-1631. PubMed ID: 27916094
[TBL] [Abstract][Full Text] [Related]
11. Autophagy modulates mesenchymal-to-endothelial transition via p53.
Hu J; Kong S; Dong T; Lin Z; Zhang Q; Chen X; Gong Y; Fan X; He M; Zhou H
Aging (Albany NY); 2020 Nov; 12(21):22112-22121. PubMed ID: 33186920
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
Shen C; Jiang Y; Li Q; Liu C; Hu F; Li M
J Dermatol Sci; 2021 Aug; 103(2):82-92. PubMed ID: 34266726
[TBL] [Abstract][Full Text] [Related]
13. [Role of interleukin-6 in human umbilical vein endothelial cell to mesenchymal cell transformation].
Guo L; He J; Cui L; Mi JW; Zhang S; Sun JH; Du J; Wen DL; Zhang HC; Jiang JX; Wang JM; Huang H
Zhonghua Shao Shang Za Zhi; 2021 May; 37(5):420-428. PubMed ID: 34044524
[No Abstract] [Full Text] [Related]
14. High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell.
Yu CH; Suriguga ; Gong M; Liu WJ; Cui NX; Wang Y; Du X; Yi ZC
Exp Mol Pathol; 2017 Jun; 102(3):377-383. PubMed ID: 28347704
[TBL] [Abstract][Full Text] [Related]
15. DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis.
Liu C; Tang J; Luo W; Liu S; Sun X; Hong W; Zhou X; Lu J; Li M; Zhu L
Rheumatology (Oxford); 2023 Feb; 62(2):934-945. PubMed ID: 35686918
[TBL] [Abstract][Full Text] [Related]
16. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
20. Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations.
Wen T; Du L; Chen B; Yan D; Yang A; Liu J; Gu N; Meng J; Xu H
Part Fibre Toxicol; 2019 Jul; 16(1):30. PubMed ID: 31300057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]